GlassScriptPhysician profile
Bridget R Moore
NPI 1669727251
$1,534.39
in general payments reported to CMS, 2019-2025
23 companies · $391 in 2025
The $391 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $155 · 2020: $112 · 2021: $173 · 2022: $104 · 2023: $562 · 2024: $36.25 · 2025: $391.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $730 · Travel and Lodging: $260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $729.98 |
| Travel and Lodging | $259.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $560.98 | 2022-2025 | |
| Smith+Nephew, INC. | $132.31 | 2019-2024 | Bone Anchors With Arthroscopic Delivery System, Stravix, Grafix Pl |
| Convatec INC. | $131.31 | 2023 | |
| Peerless Surgical INC. | $120.93 | 2019-2025 | |
| Paratek Pharmaceuticals, INC. | $87.74 | 2022-2025 | Nuzyra |
| Sebela Pharmaceuticals INC. | $79.05 | 2019-2022 | |
| Integra Lifesciences Corporation | $65.42 | 2020-2021 | |
| Musculoskeletal Transplant Foundation INC. | $65.03 | 2019-2020 | |
| Horizon Therapeutics Plc | $43.98 | 2023 | Krystexxa |
| Abbott Laboratories | $30.12 | 2023 | Proclaim |
| Depuy Synthes Sales INC. | $30.08 | 2022-2023 | Na |
| Grt US Holding, INC. | $29.89 | 2021 | |
| Abbvie INC. | $23.17 | 2023 | |
| Kerecis Limited | $16.40 | 2022 | |
| Triad Life Sciences INC. | $16.40 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $14.59 | 2019 | |
| Osiris Therapeutics INC. | $14.08 | 2019 | |
| Cashflow Solutions, LLC | $13.19 | 2023 | Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White |
| Sanara Medtech INC. | $13.00 | 2021 | |
| Melinta Therapeutics, LLC | $12.87 | 2019 | |
| Stryker Corporation | $11.54 | 2021 | |
| Paragon 28, INC. | $11.43 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $10.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bridget Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.